Redox-responsive nanoparticles self-assembled from porphyrin-betulinic acid conjugates for chemo- and photodynamic therapy
Source abstract
Abstract
Abstract The redox-responsive nanoparticle (NanoP-ss-BA) is designed by linking the porphyrin derivative (P) to the naturally occurring betulinic acid (BA) through a disulphide bond. A GSH triggered disassembly of NanoP-ss-BA effectively promotes a singlet oxygen (1O2) production, but also releases lipophilic anticancer drug, BA in situ. Beside this, high phototoxicity of NanoP-ss-BA serves it as a good candidate for photodynamic therapy (PDT).
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics · Porphyrin and Phthalocyanine Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Redox responsive xylan-SS-curcumin prodrug nanoparticles for dual drug delivery in cancer therapy10.1016/j.msec.2019.110356 ↗
2. Photodynamic therapy of cancer: an update
3. Update of the situation of clinical photodynamic therapy in Europe in the 2003–2018 period10.1142/S1088424619300027 ↗
4. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
5. Supramolecular photosensitizers rejuvenate photodynamic therapy10.1039/C7CS00594F ↗
6. Sphere–like aggregates of porphyrin as phototherapeutic agent for synergistic cancer treatment10.1016/j.dyepig.2020.108926 ↗
7. Sonodynamic and chemodynamic therapy based on organic/organometallic sensitizers10.1016/j.ccr.2020.213610 ↗
8. Reactive oxygen species (ROS)-based nanomedicine10.1021/acs.chemrev.8b00626 ↗
9. Overcoming the Achilles' heel of photodynamic therapy10.1039/C6CS00616G ↗
10. Microenvironment-activated nanoparticles for oxygen self-supplemented photodynamic cancer therapy10.1039/C9BM01537J ↗
11. Facile supramolecular approach to nucleic-acid-driven activatable nanotheranostics that Overcome Drawbacks of Photodynamic Therapy10.1021/acsnano.7b07809 ↗
12. Multifunctional nanoparticles self‐assembled from small organic building blocks for biomedicine10.1002/adma.201600906 ↗
13. Biocompatible conjugated porphyrin nanoparticles with photodynamic/photothermal performances in cancer therapy10.1016/j.dyepig.2020.108664 ↗
14. Nanocarriers as an emerging platform for cancer therapy10.1038/nnano.2007.387 ↗
15. Stimuli-responsive nanocarriers for drug delivery10.1038/nmat3776 ↗
16. Activatable photosensitizers: agents for selective photodynamic therapy10.1002/adfm.201604053 ↗
17. Activatable triplet photosensitizers: magic bullets for targeted photodynamic therapy10.1039/C4TC00659C ↗
18. Tumor microenvironment and intracellular signal-activated nanomaterials for anticancer drug delivery10.1016/j.mattod.2015.11.025 ↗
19. Role of glutathione in cancer: from mechanisms to therapies10.3390/biom10101429 ↗
20. Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor10.1080/10717544.2018.1451571 ↗
21. Redox-responsive self-assembly PEG nanoparticle enhanced triptolide for efficient antitumor treatment10.1038/s41598-018-29692-0 ↗
22. A dual-responsive nanocapsule via disulfide-induced self-assembly for therapeutic agent delivery10.1039/C5SC03707G ↗
23. MMP2-targeting and redox-responsive PEGylated chlorin e6 nanoparticles for cancer near-infrared imaging and photodynamic therapy10.1021/acsami.5b10772 ↗
24. Photodynamic therapy based on organic small molecular fluorescent dyes10.1016/j.cclet.2019.04.017 ↗
25. Cancer, photodynamic therapy and porphyrin-type derivatives10.1590/0001-3765201820170811 ↗
26. Betulinic acid and its derivatives as potential antitumor agents10.1002/med.21353 ↗
27. Betulin and betulinic acid in cancer research10.26444/jpccr/92743 ↗
28. Water soluble multiarm-polyethylene glycol–betulinic acid prodrugs: design, synthesis, and in vivo effectiveness10.1039/C4PY00648H ↗
29. Modifications of porphyrins and hydroporphyrins for their solubilization in aqueous media10.3390/molecules22060980 ↗
30. Spermine amides of selected triterpenoid acids: dynamic supramolecular systems formation influences cytotoxicity of the drugs10.1039/C9TB01957J ↗
31. Amides derived from heteroaromatic amines and selected steryl hemiesters10.1016/j.steroids.2013.10.003 ↗
32. Picolyl amides of betulinic acid as antitumor agents causing tumor cell apoptosis10.1016/j.ejmech.2017.12.096 ↗
33. Amphiphilic derivatives of (3β,17β)-3-hydroxyandrost-5-ene-17-carboxylic acid10.1016/j.steroids.2017.10.011 ↗
34. Enhancing effect of cystamine in its amides with betulinic acid as antimicrobial and antitumor agent in vitro10.1016/j.steroids.2019.04.004 ↗
35. N‐Dimethyl‐4‐pyridinamine, a very effective acylation catalyst10.1002/anie.196909811 ↗
36. Polyamine derivatives of betulinic acid and β-sitosterol: a comparative investigation10.1016/j.steroids.2015.04.005 ↗
37. Nanomaterials for cancer therapy and imaging10.1007/s10059-011-0051-5 ↗
38. Effects of size and surface charge of polymeric nanoparticles on in vitro and in vivo applications10.4236/jbnb.2016.72011 ↗
39. Expanded theory of H- and J-molecular aggregates: the effects of vibronic coupling and intermolecular charge transfer10.1021/acs.chemrev.7b00581 ↗
40. Substituent-control exciton in J-aggregates of protonated water-insoluble porphyrins10.1021/ja017768j ↗
41. Virus-templated assembly of porphyrins into light-harvesting nanoantennae10.1021/ja908812b ↗
42. Self‐assembly of porphyrin–paclitaxel conjugates into nanomedicines: enhanced cytotoxicity due to endosomal escape10.1002/asia.201600423 ↗
43. Simple peptide‐tuned self‐assembly of photosensitizers towards anticancer photodynamic therapy10.1002/anie.201509810 ↗
44. Disulfide‐bridged organosilica frameworks: designed, synthesis, redox‐triggered biodegradation, and nanobiomedical applications10.1002/adfm.201707325 ↗
45. Design of superior phototheranostic agents guided by Jablonski diagrams10.1039/D0CS00671H ↗